Medicare Pauses New Medical Supply Company Enrollments to Fight Fraud

You might care about this because the government has stopped accepting new applications from medical supply companies that want to bill Medicare. The Centers for Medicare & Medicaid Services, or CMS, announced a temporary, nationwide pause, also called a moratorium. This pause started on February 27, 2026, and will last for six months. CMS can extend this pause if needed. This action is part of a larger effort to prevent fraud, waste, and abuse in federal healthcare programs like Medicare, Medicaid, and the Children's Health Insurance Program (CHIP). The Affordable Care Act gave CMS the power to do this. This decision follows many reports from the Office of Inspector General, or OIG, which have consistently pointed out significant problems with fraud involving medical equipment suppliers. The OIG has warned about billions of dollars in improper payments. CMS also looked at its own data. This data showed trends in enrollments and claims, and revealed issues like revoked billing privileges or investigations into fraud. The goal is to protect taxpayer money and ensure that patients receive proper care without unnecessary or substandard items. CMS has used these types of pauses before for other healthcare providers to address similar concerns. What is particularly interesting about this notice is how CMS is actively using its authority to combat fraud in a specific area. While CMS has used moratoria before, applying a nationwide pause on Durable Medical Equipment, Prosthetics, Orthotics, and Supplies (DMEPOS) supplier medical supply companies highlights a persistent and costly problem. The document emphasizes that fraud in this sector has been a serious issue for many years. It has cost taxpayers hundreds of millions, even billions, of dollars. It can also lead to patient harm when people get unnecessary or poor-quality medical items. The fact that the OIG has raised concerns for over a decade and found "new schemes" shows that this type of fraud is constantly evolving. This nationwide moratorium demonstrates CMS's commitment to protecting the integrity of these programs. It aims to stop new companies that might engage in fraudulent activities from entering the system. This protective step allows CMS and law enforcement to focus on existing issues and develop better safeguards. It shows a proactive approach to managing risks within the complex healthcare system. Many different groups would find this legal document highly relevant. Medical supply companies, especially those that provide Durable Medical Equipment, Prosthetics, Orthotics, and Supplies, will be directly affected. New companies trying to enroll in Medicare will find their applications on hold for at least six months. Existing medical supply companies should also pay attention. This action signals heightened scrutiny of the industry. Healthcare lawyers and compliance officers working with medical suppliers or other healthcare providers will need to understand these rules. They will also need to know the exceptions to the moratorium. Taxpayers and policymakers will be interested because the document discusses efforts to save billions of dollars by preventing fraud, waste, and abuse. Researchers and academics studying healthcare policy, fraud detection, or the financial integrity of federal programs will also find this notice useful. Patients and their advocates might also care. The document explains how fraud can lead to unnecessary or substandard items, which can harm patient care. Finally, state Medicaid and Children's Health Insurance Program (CHIP) agencies are also relevant parties. This is because state programs must comply with federal moratoria unless it impacts access to care.